Owing to the difficulties in identifying anaerobic, non-sporulating, Gram-positive bacilli in clinical microbiology laboratories, the epidemiology and clinical spectrum of disease of many of these bacteria have been poorly understood. The application of 16S rRNA gene sequencing in characterizing bacteraemia due to anaerobic, non-sporulating Gram-positive bacilli during a 4-year period is described. The first case of Olsenella uli bacteraemia, in a patient with acute cholangitis, is also reported. Among 165 blood culture isolates of anaerobic, Gram-positive bacilli, 75 were identified as Propionibacterium acnes by phenotypic tests and 21 as members of other anaerobic, non-sporulating Gram-positive bacilli by 16S rRNA gene sequencing. Of these 96 isolates, 16 (17 %) were associated with cases of clinically significant bacteraemia, among which 10 (63 %) were caused by Eggerthella, four (25 %) by Lactobacillus and one (6 %) by each of Eubacterium tenue and O. uli. Five of the 10 Eggerthella isolates were Eggerthella lenta, whereas the other five belonged to two novel Eggerthella species, with Eggerthella hongkongensis being almost as prevalent as Eggerthella lenta. Underlying disease in the gastrointestinal tract, isolation of Eggerthella and Lactobacillus, and monomicrobial bacteraemia were associated with clinically significant bacteraemia, whereas isolation of P. acnes and polymicrobial bacteraemia were associated with pseudobacteraemia. Most patients with clinically significant bacteraemia had underlying diseases, with diseases in the gastrointestinal tract being most common. The overall mortality rate was 31 %. Immunocompromised patients with clinically significant bacteraemia due to anaerobic, non-sporulating, Gram-positive bacilli other than P. acnes should be treated with appropriate antibiotics. The unexpected frequency of isolation of Eggerthella from blood cultures and its association with clinically significant disease suggest that this genus is probably of high pathogenicity. Further studies to look for specific virulence factors are warranted.
INTRODUCTION
Medically important anaerobic, non-sporulating, Grampositive bacilli include members of the genera Actinomyces, Bifidobacterium, Eggerthella, Eubacterium, Lactobacillus and Propionibacterium. Identification of this group of bacteria in clinical microbiology laboratories is difficult. Analysis of cell wall peptidoglycans and metabolic end products by GC-MS, which is important for accurate identification to the genus level, requires special equipment and expertise, and is usually not available in clinical laboratories. Moreover, these organisms are often unrecognized in clinical specimens because of their complex transport and growth requirements, and frequent co-existence of less fastidious, aerobic bacteria in mixed infections. As a result, the epidemiology, clinical spectrum of disease and pathogenic potential of the various genera are not fully understood.
Comparison of the gene sequences of bacterial species has shown that the 16S rRNA gene is highly conserved within a species and among species of the same genus. Thus it can be used as the new standard for classification and identification of bacteria (Relman et al., 1990 (Relman et al., , 1992 . Recently, we have reported the application of this technique for identifying species of this group of bacteria, including a strain of Lactobacillus salivarius isolated from a patient with cholecystitis (Woo et al., 2002a) and a strain of Actinomyces odontolyticus from a patient with pelvic inflammatory disease (Woo et al., 2002b) , and for the discovery of a novel Actinomyces species (Woo et al., 2003) and two novel Eggerthella species (Lau et al., 2004) . In this article, using 16S rRNA gene sequencing as the standard of bacterial identification, we define the epidemiology, clinical disease spectrum and outcome of patients with bacteraemia due to anaerobic, nonsporulating, Gram-positive bacilli during a 4-year period.
METHODS
Patients and microbiological methods. The bacterial strains used in this study were isolates from blood cultures of patients hospitalized at the Queen Mary Hospital in Hong Kong during a 4-year period (January 1998 to December 2001 . Clinical data were collected prospectively as described in our previous publication (Luk et al., 1998) . Clinical specimens were collected and handled according to standard protocols (Murray et al., 1999) . The BACTEC 9240 blood culture system (Becton Dickinson) was used. All anaerobic Gram-positive bacilli isolated from blood cultures were identified to the species level. Isolates were identified as Clostridium perfringens by the presence of double zone haemolysis on blood agar, the ability to produce lecithinase on egg yolkglucose agar and by the Vitek system (ANI) (bioMérieux Vitek). Isolates of Propionibacterium acnes were identified by the ability to produce catalase and indole, and by the Vitek system (ANI). All isolates other than C. perfringens and P. acnes were subjected to 16S rRNA gene sequencing. All isolates finally identified as species belonging to genera of anaerobic, non-sporulating, Gram-positive bacilli were included in this study. Each isolate was categorized as clinically significant or a contaminant (pseudobacteraemia) by clinical and laboratory criteria as described in a previous study (Weinstein et al., 1997) . The criteria included the patients' clinical presentation, physical examination findings, body temperature at the time of the blood culture, leukocyte and differential cell counts, imaging or operative findings, histopathological results, number of positive blood cultures out of the total number performed, and response to treatment. The same isolate recovered from the same patient was counted only once.
Extraction of bacterial DNA for 16S rRNA gene sequencing.
Bacterial DNA extraction was modified from our previously published protocol (Lau et al., 2003; Woo et al., 2002c) . Briefly, 80 ìl NaOH (0 . 05 M) was added to 20 ìl of a loopful of bacterial cells suspended in 100 ìl distilled water and the mixture was incubated at 60 8C for 45 min, followed by addition of 6 ìl Tris/HCl (pH 7 . 0), achieving a final pH of 8 . 0. The resultant mixture was diluted 3100 and 5 ìl of the diluted extract was used for PCR.
PCR, gel electrophoresis and 16S rRNA gene sequencing. PCR amplification and DNA sequencing of the 16S rRNA genes were performed according to our previous publications (Woo et al., 2002a, b; Yuen et al., 2001) . Briefly, DNase-I-treated distilled water and PCR master mix [which contained deoxynucleoside triphosphates (dNTPs), PCR buffer and Taq polymerase] were used in all PCR reactions by adding 1 U DNase I (Pharmacia) to 40 ìl distilled water or PCR master mix, and incubating the mixture at 25 8C for 15 min and subsequently at 95 8C for 10 min to inactivate the DNase I. The bacterial DNA extracts and control were amplified with 0 . 5 ìM primers [LPW81 (59-TGGCGAACGGGTGAGTAA-39) and LPW58 (59-AGGCCCGGGAA CGTATTCAC-39), corresponding to nucleotide positions 91-1350 of the 16S rRNA gene of Eggerthella lenta, GenBank accession no. AB011817] (Gibco-BRL). The PCR mixture (50 ìl) contained bacterial DNA, PCR buffer (10 mM Tris/HCl, pH 8 . 3; 50 mM KCl; 2 mM MgCl 2 ; and 0 . 01 % gelatin), 200 ìM of each dNTP and 1 . 0 U Taq polymerase (Boehringer Mannheim). The mixtures were amplified in 40 cycles of 94 8C for 1 min, 55 8C for 1 min and 72 8C for 2 min, and a final extension at 72 8C for 10 min, in an automated 0 . 5 ml GeneAmp PCR system 9700 (Applied Biosystems). DNase-I-treated distilled water was used as the negative control. Ten microlitres of each amplified product was electrophoresed in a 1 . 0 % (w/v) agarose gel with a molecular size marker (lambda DNA AvaII digest; Boehringer Mannheim) in parallel. Electrophoresis in Tris/borate/EDTA buffer was performed at 100 V for 1 . 5 h. The gel was stained with ethidium bromide (0 . 5 ìg ml À1 ) for 15 min, rinsed and photographed under UV light illumination.
The PCR products were gel-purified using the QIAquick PCR purification kit (QIAgen). Both strands of the PCR products were sequenced twice with an ABI 377 automated sequencer according to the manufacturer's instructions (Perkin-Elmer), using the PCR primers LPW58 and LPW81. The 16S rRNA gene sequences of novel Eggerthella species were further determined by PCR and sequencing as described in our previous publication (Lau et al., 2004) . The sequences of the PCR products were compared with known 16S rRNA gene sequences in GenBank (http:// www.ncbi.nlm.nih.gov) by multiple sequence alignment using the CLUSTAL W program (Thompson et al., 1994) .
Statistical analysis. A comparison of characteristics was made between patients with clinically significant bacteraemia and those with pseudobacteraemia due to anaerobic, non-sporulating, Gram-positive bacilli. The chi-square test was used for categorical variables and the Student's t-test for age. P , 0 . 05 was regarded as statistically significant.
RESULTS

Identification of anaerobic, non-sporulating, Grampositive bacilli
A total of 165 anaerobic Gram-positive bacilli were isolated from the blood cultures during the 4-year study period. Of the 165 isolates, 51 were identified as C. perfringens and 75 as P. acnes by conventional phenotypic tests. The remaining 39 isolates were subjected to 16S rRNA gene sequencing. PCR of the 16S rRNA genes of these isolates showed bands at about 1200 bp. Sequencing of the 16S rRNA genes revealed that 21 had 16S rRNA genes with 92 . 7-100 % nucleotide identity with those of known species belonging to genera of anaerobic, non-sporulating, Gram-positive bacilli, indicating that they were anaerobic, non-sporulating, Gram-positive bacilli ( Table 1) . The remaining 17 isolates were identified as Clostridium species and one isolate as a novel bacterial genus and species and will not be discussed in the present report. The 96 blood culture isolates of anaerobic, non-sporulating, Gram-positive bacilli (75 of P. acnes and 21 of other species) were recovered from 96 different patients. Out of these 96 isolates, 16 (17 %) were associated with clinically significant bacteraemia, while the remaining 80 (83 %) were associated with pseudobacteraemia due to contamination. Ten of the 16 cases (63 %) of clinically significant bacteraemia were caused by Eggerthella spp., four (25 %) by Lactobacillus spp. and one (6 %) by each of Eubacterium tenue and Olsenella uli ( Table  2) . Five of the 10 Eggerthella isolates belonged to two novel Eggerthella spp., which have been described recently (Lau et al., 2004) . All the 75 isolates of P. acnes, three isolates of Lactobacillus spp. and one each of Eubacterium tenue and Bifidobacterium pseudocatenulatum were associated with pseudobacteraemia.
Patient characteristics
The characteristics of the 16 patients with clinically significant bacteraemia due to anaerobic, non-sporulating, Grampositive bacilli are tabulated and summarized in Tables 2 and 3. The clinical details of patient 15 with Lactobacillus cholecystitis have been described previously (Woo et al., 2002a) . The incidence of anaerobic, non-sporulating, Grampositive bacilli bacteraemia was similar throughout the 4year study period and there was no obvious seasonal variation. The median age was 62 (range 27-87). Ten patients (63 %) were over 60. The characteristics of patients with clinically significant bacteraemia and those with pseudobacteraemia due to anaerobic, non-sporulating, Gram-positive bacilli are compared and summarized in Table 3 . Underlying gastrointestinal tract disease, isolation of Eggerthella and Lactobacillus species, and monomicrobial bacteraemia were associated with clinically significant bacteraemia (P ¼ 0 . 003, P , 0 . 0005, P ¼ 0 . 014 and P ¼ 0 . 002, respectively), whereas isolation of P. acnes and polymicrobial bacteraemia were associated with pseudobacteraemia (P , 0 . 0005 and P ¼ 0 . 002, respectively).
DISCUSSION
In this study, we defined the epidemiology, clinical spectrum and outcome of bacteraemia due to anaerobic, non-sporulating, Gram-positive bacilli with the aid of 16S rRNA gene sequencing. Almost all patients with clinically significant bacteraemia had underlying diseases, with gastrointestinal tract disease and malignancy being the most common. Most patients (75 %) had community-acquired bacteraemia. Among the 10 patients with documented foci of infection, the gastrointestinal and hepatobiliary tracts were the major portal of entry. The four patients with hospital-acquired infection had primary bacteraemia of which the source was unidentified. The most common genus associated with clinically significant bacteraemia was Eggerthella (63 %), followed by Lactobacillus (25 %).
From the present report, Eggerthella is always of clinical significance when isolated from blood cultures. In contrast to the rare reports of Eggerthella bacteraemia in the literature, the present study suggests that this genus is an important cause of clinically significant bacteraemia due to anaerobic, non-sporulating, Gram-positive bacilli, and that the novel species Eggerthella hongkongensis may be as prevalent as the previously sole species, E. lenta (Lau et al., 2004) . Further studies should be carried out to investigate the presence of specific virulence factors in this bacterial genus. As for Lactobacillus bacteraemia, previous reports have identified immunosuppression and prolonged hospitalization as predisposing factors (Husni et al., 1997; Salminen et al., 2004) . This is in line with the present study, where all four patients with clinically significant Lactobacillus bacteraemia had severe underlying diseases and three acquired the infection in hospital. Although Lactobacillus appeared to be associated with clinically significant bacteraemia in the present study, which is likely the result of the huge number of cases of Propionibacterium pseudobacteraemia, three cases of pseudobacteraemia were identified of undetermined clinical significance. Nevertheless, previous studies have suggested that most lactobacilli in blood cultures are of clinical significance and treatment with antimicrobials effective in vitro was associated with lower mortality (Husni et al., 1997; Salminen et al., 2004) .
Bacteraemia due to anaerobic, non-sporulating, Gram-positive bacilli other than P. acnes should be managed cautiously. Although no studies have been conducted to evaluate the effect of antimicrobial therapy on the clinical outcome except for Lactobacillus bacteraemia (Salminen et al., 2004) , the clinical significance of each case should be evaluated individually. The attributable mortality of clinically significant bacteraemia in this study was high (31 %) and all the five patients who died had severe underlying diseases. Therefore, when bacteraemia due to anaerobic, non-sporulating, Grampositive bacilli occurs in immunocompromised patients, appropriate antibiotic treatment should be initiated and the source of the bacteraemia identified.
The present study also uncovered the first case of O. uli bacteraemia in humans. O. uli was first described in 1991 by Olsen after its isolation from human gingival crevices and periodontal pockets (Olsen et al., 1991) . It was formerly known as Lactobacillus uli but was reclassified under the new genus Olsenella in 2001 on the basis of phenotypic characteristics and 16S rRNA sequence analysis (Dewhirst et al., 2001) . Apart from its isolation from the oral cavity of patients with periodontitis, the bacterium has not been reported to cause other infections (Dewhirst et al., 2001; Downes et al., 2001) . The present patient (patient 16) with O. uli bacteraemia was admitted for acute cholangitis because of a blocked percutaneous biliary drain which had been inserted Anaerobic non-sporulating Gram-positive bacilli bacteraemia for malignant biliary obstruction. O. uli was isolated from his blood culture taken on admission. The patient was treated with cefuroxime and revision of the biliary drain. Since he did not have dental problems, it is likely that the biliary tract was the source of the bacterium, which had ascended from the gastrointestinal tract. The application of 16S rRNA gene sequencing to clinically significant isolates of anaerobic Gram-positive bacilli may help further identify more cases of O. uli infections and define its epidemiology and pathogenicity.
Identification of anaerobic, non-sporulating, Gram-positive bacilli is difficult, as many of them are slow-growing, fastidious and biochemically inert. By 16S rRNA gene analysis, revisions have been made in their classification, and new genera and species introduced (Kageyama & Benno, 2000; Kageyama et al., 1999; Lau et al., 2004; Nakazawa et al., 1999; Wade et al., 1999) . Moreover, such application has allowed unambiguous identification of these bacteria. In one study, 105 Eubacterium-like isolates from odontogenic infections, infections associated with dental implants or saliva from healthy subjects were subjected to 16S rRNA gene analysis . Ninety-one of the isolates were identified as belonging to 10 previously described genera while the remaining 14 did not correspond to existing species. This illustrates the diversity of organisms provisionally identified as Eubacterium and the potential of 16S rRNA gene analysis in the discovery of previously mis-identified, novel bacteria. Recently, we have also reported the use of this technique for identifying and defining the clinical significance of a strain of L. salivarius (Woo et al., 2002a ) and a strain of A. odontolyticus (Woo et al., 2002b) , and for the discovery of a novel Actinomyces species (Woo et al., 2003) and two novel Eggerthella species (Lau et al., 2004) . Others have reported the application of a simpler approach, amplified 16S rDNA restriction analysis, to identify clinical isolates of putative Actinomyces spp. (Hall et al., 2001) . They found that only 70 % of the isolates analysed belonged to recognized Actinomyces species while others were either novel species or members of other genera. Further application of similar techniques in identifying clinically important isolates of anaerobic, non-sporulating, Gram-positive bacilli will better define the epidemiology, clinical significance and pathogenic potential of the various genera.
